IRINOTECAN SUN 1,5 mg/ml, solution pour perfusion — 1 poche(s) unidose(s) sans-PVC suremballée(s)/surpochée(s) aluminium de 220 ml

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400955072034
  • CIP7 5507203
  • CIS 68644553

What the source publishes

Holder
SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
Active ingredients
CHLORHYDRATE D'IRINOTÉCAN TRIHYDRATÉ, IRINOTÉCAN
Form
solution pour perfusion
Package
1 poche(s) unidose(s) sans-PVC suremballée(s)/surpochée(s) aluminium de 220 ml
Routes
intraveineuse
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2020-02-18
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400955072034
{
  "cis": "68644553",
  "cip7": "5507203",
  "form": "solution pour perfusion",
  "name": "IRINOTECAN SUN 1,5 mg/ml, solution pour perfusion — 1 poche(s) unidose(s) sans-PVC suremballée(s)/surpochée(s) aluminium de 220 ml",
  "cip13": "3400955072034",
  "holder": "SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)",
  "routes": [
    "intraveineuse"
  ],
  "holders": [
    "SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2020-02-18",
  "compositions": [
    {
      "name": "CHLORHYDRATE D'IRINOTÉCAN TRIHYDRATÉ",
      "nature": "SA",
      "strength": "1,5 mg",
      "linkageNumber": "1",
      "substanceCode": "20915",
      "dosageReference": "1 mL de solution pour perfusion",
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "IRINOTÉCAN",
      "nature": "FT",
      "strength": "1,3 mg",
      "linkageNumber": "1",
      "substanceCode": "73952",
      "dosageReference": "1 mL de solution pour perfusion",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "IRINOTECAN SUN 1,5 mg/ml, solution pour perfusion",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "1 poche(s) unidose(s) sans-PVC suremballée(s)/surpochée(s) aluminium de 220 ml",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2022-01-19",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CHLORHYDRATE D'IRINOTÉCAN TRIHYDRATÉ",
    "IRINOTÉCAN"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400955072034"